NeuroOne Medical Technologies Corporation (NMTC)
USD 0.74
(-6.41%)
USD 0.74
(-6.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.84 Million USD | -42.58% |
| 2022 | 3.21 Million USD | 132.43% |
| 2021 | 1.38 Million USD | -48.6% |
| 2020 | 2.69 Million USD | 52.16% |
| 2019 | 1.77 Million USD | -61.64% |
| 2018 | 4.61 Million USD | -12.71% |
| 2017 | 5.28 Million USD | 416.7% |
| 2016 | 1.02 Million USD | 1127.83% |
| 2015 | 83.33 Thousand USD | 134.11% |
| 2014 | 35.59 Thousand USD | 15.5% |
| 2013 | 30.81 Thousand USD | 67.89% |
| 2012 | 18.35 Thousand USD | 7.16% |
| 2011 | 17.12 Thousand USD | 27.33% |
| 2010 | 13.45 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.54 Million USD | 9.7% |
| 2024 Q3 | 1.9 Million USD | 23.4% |
| 2024 Q1 | 1.4 Million USD | -24.01% |
| 2023 Q3 | 1.83 Million USD | 9.84% |
| 2023 Q4 | 1.84 Million USD | 0.6% |
| 2023 FY | 1.84 Million USD | -42.58% |
| 2023 Q1 | 1.48 Million USD | -53.75% |
| 2023 Q2 | 1.67 Million USD | 12.35% |
| 2022 FY | 3.21 Million USD | 132.43% |
| 2022 Q1 | 1.23 Million USD | -10.76% |
| 2022 Q4 | 3.21 Million USD | 237.88% |
| 2022 Q3 | 952.47 Thousand USD | -1.43% |
| 2022 Q2 | 966.27 Thousand USD | -21.8% |
| 2021 Q3 | 953.81 Thousand USD | -9.77% |
| 2021 Q1 | 6.5 Million USD | 141.49% |
| 2021 Q2 | 1.05 Million USD | -83.75% |
| 2021 FY | 1.38 Million USD | -48.6% |
| 2021 Q4 | 1.38 Million USD | 45.16% |
| 2020 Q4 | 2.69 Million USD | -67.89% |
| 2020 Q1 | 7.27 Million USD | 310.76% |
| 2020 Q2 | 6.57 Million USD | -9.58% |
| 2020 FY | 2.69 Million USD | 52.16% |
| 2020 Q3 | 8.38 Million USD | 27.6% |
| 2019 Q4 | 1.77 Million USD | -2.17% |
| 2019 Q3 | 1.8 Million USD | -15.05% |
| 2019 Q1 | 5.53 Million USD | 45.77% |
| 2019 Q2 | 2.13 Million USD | -61.52% |
| 2019 FY | 1.77 Million USD | -61.64% |
| 2018 FY | 4.61 Million USD | -12.71% |
| 2018 Q4 | 3.79 Million USD | -49.49% |
| 2018 Q3 | 7.51 Million USD | 13.26% |
| 2018 Q2 | 6.63 Million USD | 25.57% |
| 2018 Q1 | 5.28 Million USD | 39.24% |
| 2017 Q1 | 677.19 Thousand USD | 518.33% |
| 2017 Q2 | 104.87 Thousand USD | -84.51% |
| 2017 Q3 | 128.49 Thousand USD | 22.52% |
| 2017 Q4 | 3.79 Million USD | 2854.7% |
| 2017 FY | 5.28 Million USD | 416.7% |
| 2016 Q1 | 83.33 Thousand USD | 29.95% |
| 2016 FY | 1.02 Million USD | 1127.83% |
| 2016 Q4 | 109.52 Thousand USD | 5.5% |
| 2016 Q3 | 103.8 Thousand USD | 19.92% |
| 2016 Q2 | 86.56 Thousand USD | 3.88% |
| 2015 FY | 83.33 Thousand USD | 134.11% |
| 2015 Q2 | 35.16 Thousand USD | -1.2% |
| 2015 Q4 | 64.12 Thousand USD | 11.54% |
| 2015 Q3 | 57.48 Thousand USD | 63.47% |
| 2015 Q1 | 35.59 Thousand USD | 36.32% |
| 2014 Q2 | 3875.00 USD | -87.43% |
| 2014 Q1 | 30.81 Thousand USD | 6.61% |
| 2014 FY | 35.59 Thousand USD | 15.5% |
| 2014 Q4 | 26.11 Thousand USD | 30.09% |
| 2014 Q3 | 20.07 Thousand USD | 417.99% |
| 2013 Q4 | 28.9 Thousand USD | 7.04% |
| 2013 FY | 30.81 Thousand USD | 67.89% |
| 2013 Q2 | 22.67 Thousand USD | 23.55% |
| 2013 Q1 | 18.35 Thousand USD | 6.12% |
| 2013 Q3 | 27 Thousand USD | 19.08% |
| 2012 FY | 18.35 Thousand USD | 7.16% |
| 2012 Q3 | 17.24 Thousand USD | 0.38% |
| 2012 Q4 | 17.29 Thousand USD | 0.28% |
| 2012 Q2 | 17.18 Thousand USD | 0.32% |
| 2012 Q1 | 17.12 Thousand USD | 0.33% |
| 2011 Q1 | 13.45 Thousand USD | 0.0% |
| 2011 FY | 17.12 Thousand USD | 27.33% |
| 2011 Q4 | 17.07 Thousand USD | 0.31% |
| 2011 Q3 | 17.02 Thousand USD | 0.0% |
| 2010 FY | 13.45 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 96.63% |
| Axonics, Inc. | 82.35 Million USD | 97.756% |
| INVO Bioscience, Inc. | 19.99 Million USD | 90.758% |
| CVRx, Inc. | 39.28 Million USD | 95.296% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 99.172% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 41.925% |
| MaxCyte, Inc. | 36.1 Million USD | 94.882% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 91.4% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.509% |
| Sintx Technologies, Inc. | 6.59 Million USD | 71.972% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 96.395% |
| Apyx Medical Corporation | 52.31 Million USD | 96.468% |
| Cutera, Inc. | 518.12 Million USD | 99.643% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 65.408% |
| NeuroPace, Inc. | 86.99 Million USD | 97.876% |
| IRIDEX Corporation | 24.91 Million USD | 92.583% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 97.895% |
| enVVeno Medical Corporation | 2.43 Million USD | 24.11% |
| TELA Bio, Inc. | 59.16 Million USD | 96.877% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.711% |
| UFP Technologies, Inc. | 118.04 Million USD | 98.435% |
| Modular Medical, Inc. | 2.27 Million USD | 18.666% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 93.699% |
| LENSAR, Inc. | 22.4 Million USD | 91.754% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.916% |
| Surmodics, Inc. | 65.82 Million USD | 97.193% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 82.092% |
| Inogen, Inc. | 121.38 Million USD | 98.478% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -10.389% |
| RxSight, Inc. | 22.18 Million USD | 91.672% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -334.515% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 93.753% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 92.012% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -334.515% |
| PetVivo Holdings, Inc. | 2.42 Million USD | 23.932% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 98.233% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.737% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 92.743% |
| Dynatronics Corporation | 11.78 Million USD | 84.313% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 96.423% |
| InMode Ltd. | 75.91 Million USD | 97.566% |
| Bruker Corporation | 2.83 Billion USD | 99.935% |
| Movano Inc. | 5.97 Million USD | 69.057% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.434% |
| FONAR Corporation | 57.45 Million USD | 96.784% |
| BioSig Technologies, Inc. | 4.68 Million USD | 60.557% |
| Envoy Medical, Inc. | 9.4 Million USD | 80.346% |
| Align Technology, Inc. | 2.45 Billion USD | 99.925% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 96.834% |
| Talis Biomedical Corporation | 29.22 Million USD | 93.677% |
| Cerus Corporation | 144.3 Million USD | 98.719% |
| 908 Devices Inc. | 37.49 Million USD | 95.071% |
| Nemaura Medical Inc. | 26.37 Million USD | 92.994% |
| Outset Medical, Inc. | 190.91 Million USD | 99.032% |
| NanoVibronix, Inc. | 2.68 Million USD | 31.202% |
| Venus Concept Inc. | 107.1 Million USD | 98.275% |
| Telesis Bio, Inc. | 40.87 Million USD | 95.479% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 98.379% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.644% |
| IRadimed Corporation | 20.73 Million USD | 91.088% |
| Tenon Medical, Inc. | 5.56 Million USD | 66.806% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 48.267% |
| Pulmonx Corporation | 60.63 Million USD | 96.952% |
| iCAD, Inc. | 8 Million USD | 76.904% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 85.439% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 95.47% |
| SI-BONE, Inc. | 61.05 Million USD | 96.973% |
| Semler Scientific, Inc. | 6.27 Million USD | 70.528% |
| Biotricity, Inc. | 35.91 Million USD | 94.855% |
| Cytosorbents Corporation | 29.98 Million USD | 93.837% |
| DexCom, Inc. | 4.19 Billion USD | 99.956% |
| ZimVie Inc. | 795.85 Million USD | 99.768% |
| Aethlon Medical, Inc. | 2.47 Million USD | 25.477% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 84.547% |
| IceCure Medical Ltd | 4.24 Million USD | 56.489% |
| PAVmed Inc | 57.13 Million USD | 96.766% |
| Sight Sciences, Inc. | 46.43 Million USD | 96.021% |
| Insulet Corporation | 1.85 Billion USD | 99.9% |
| Profound Medical Corp. | 12.66 Million USD | 85.41% |
| electroCore, Inc. | 8.94 Million USD | 79.341% |
| Bioventus Inc. | 589.79 Million USD | 99.687% |
| InspireMD, Inc. | 8.14 Million USD | 77.304% |
| PAVmed Inc. | 57.13 Million USD | 96.766% |
| Nuwellis, Inc. | 6.78 Million USD | 72.745% |
| OrthoPediatrics Corp. | 72.56 Million USD | 97.453% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 84.547% |
| BrainsWay Ltd. | 15.31 Million USD | 87.933% |
| BIOLASE, Inc. | 35.34 Million USD | 94.772% |
| Beyond Air, Inc. | 29.77 Million USD | 93.794% |
| AxoGen, Inc. | 101.16 Million USD | 98.173% |
| Inari Medical, Inc. | 209.32 Million USD | 99.117% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | 15.459% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -3.874% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.941% |
| Quanterix Corporation | 78.08 Million USD | 97.633% |
| Viveve Medical, Inc. | 10.84 Million USD | 82.964% |
| LivaNova PLC | 1.15 Billion USD | 99.84% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 89.521% |
| Varex Imaging Corporation | 668.6 Million USD | 99.724% |
| Vivani Medical, Inc. | 25.03 Million USD | 92.619% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 54.53% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 48.267% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 62.172% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.823% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.675% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 88.923% |
| NeuroMetrix, Inc. | 1.33 Million USD | -38.615% |
| Spectral AI, Inc. | 12.4 Million USD | 85.099% |
| Hyperfine, Inc. | 9.8 Million USD | 81.144% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.262% |
| Biomerica, Inc. | 2.66 Million USD | 30.608% |
| Bone Biologics Corporation | 831.4 Thousand USD | -122.264% |
| AVITA Medical, Inc. | 19.86 Million USD | 90.698% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | 6.373% |
| Silk Road Medical, Inc | 114.15 Million USD | 98.381% |